News Opinion Fellow Talk Public Reporting and the Budding Interventional Cardiologist Yashasvi Chugh, MD March 28, 2019
News Conference News ACC 2019 Time and Money: PCI Public Reporting Requirements Take Their Toll Michael O'Riordan March 26, 2019
News Conference News CRT 2019 CABG vs PCI in Left Main Disease: The Debate Continues Yael L. Maxwell March 12, 2019
News Conference News CRT 2019 ORBITA Absorbed: Principal Investigator Reflects on How Results Have Changed Her Practice Yael L. Maxwell March 07, 2019
News Daily News ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD Michael O'Riordan March 01, 2019
News Daily News Staged PCI or Complete Revasc? Physicians’ Practice Patterns Dictate Procedures Michael O'Riordan November 20, 2018
News Conference News AHA 2018 Very EARLY Invasive Angiography in NSTE ACS Patients Reduces Risk of Recurrent Ischemia Michael O'Riordan November 11, 2018
News Daily News SORT-OUT IX: Statistical Mix-up Turns Trial’s Primary Endpoint Around Michael O'Riordan November 06, 2018
News Conference News TCT 2018 Even With PSP, Bioresorbable Scaffold Falls Short in COMPARE-ABSORB and ABSORB IV Trials Michael O'Riordan September 25, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap! Shelley Wood September 25, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day Three: Intravascular Imaging and Anticoagulation Shelley Wood September 24, 2018
News Conference News TCT 2018 TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers Todd Neale September 22, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day One: ‘Back to the Future’ With Stents, Stents, and More Stents Shelley Wood September 22, 2018
News Conference News ESC 2018 BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease Todd Neale August 28, 2018
News Daily News ‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients Michael O'Riordan August 23, 2018
News Daily News New CV Risk Model Predicts Recurrent MACE at 1 Year in Post-MI Patients Michael O'Riordan August 13, 2018
News Daily News A Quarter of ‘No Option’ Patients With Refractory Angina End Up Receiving Revascularization Within 2 Years Yael L. Maxwell August 10, 2018
News Daily News ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights Michael O'Riordan July 10, 2018
News Conference News EuroPCR 2018 ORBITA Deep Dive Highlights Treatment Choices, Social Media, and Ethics Michael O'Riordan May 31, 2018
News Conference News EuroPCR 2018 Excellent Procedural Success Seen With Left Distal Access of Radial Artery Michael O'Riordan May 29, 2018